Valerie Gruber, PhD

Title(s)Professor, Psychiatry
SchoolSchool of Medicine
Address1263 Mission Street, #3107
San Francisco CA 94103
Phone415-502-0963
ORCID ORCID Icon0000-0003-4190-8384 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Kent State UniversityPh.D.1990Clinical Psychology
    UC BerkeleyM.P.H.1992School of Public Health
    University of California, San Francisco, CA2019Diversity, Equity, and Inclusion Champion Training
    Collapse Awards and Honors
    UCSF Clinical Psychology Training Program2014David Rea Training Award

    Collapse Overview 
    Collapse Overview
    VALERIE A. GRUBER is Professor in the Department of Psychiatry at UCSF, and faculty in the Public Service and Minorities Track of the UCSF Clinical Psychology Training Program. Dr. Gruber is a licensed psychologist, and National Certification for Addiction Professionals Master Addiction Counselor. She completed a Ph.D. in Clinical Psychology at Kent State University, internship at the UCSF Clinical Psychology Training Program, and an M.P.H. at the University of California Berkeley. Her clinical, supervision, leadership, teaching and research efforts focus on developing clinical interventions for substance use disorders and associated psychiatric and medical conditions that are effective for low-income adults diverse in race, culture, sexual orientation, gender identity, age, and disability. Areas of expertise include treatment of substance use and psychiatric disorders in behavioral health and primary care settings, using trauma-informed, culturally informed, anti-racist approaches to reduce health and health care disparities. Skills include motivational interviewing, individual, couples and group psychotherapy, psychological assessment, culturally responsive approaches, staff development, program management and clinical research. She has published research on behavioral, digital and structural interventions in methadone maintenance, outpatient and residential treatment, and HIV primary care.
    Collapse Global Health Equity
    Collapse Mentoring

    Collapse ORNG Applications 
    Collapse Featured Publications
    Collapse Collaboration Interests
    Collapse Academic Senate

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. S61 Racial/Ethnic Differences in Treatment-Related Barriers and Facilitators Among Patients Initiating Medication for Opioid Use Disorder (MOUD) as Part of Comprehensive Patient Navigation Programs. Drug and Alcohol Dependence. 2024 Jul 1; 260:110172. McCuistian MC, Olivas OM, Haas HA, Dauria DE, Gruber GV, Lum LP, Fokuo FJ, Tompkins TD. .
      View in: Publisher Site   Mentions:
    2. Substance use Attitudes, Beliefs, Experience, and Knowledge Among Nursing and Nursing Assistant Students. J Psychoactive Drugs. 2024 Apr 22; 1-11. Fokuo JK, Hutman PJ, Gruber VA, Masson CL, Lum PJ, Bush DM, Naugle JA, Sorensen JL. PMID: 38646910; PMCID: PMC11493843.
      View in: PubMed   Mentions:    Fields:    
    3. iVY: protocol for a randomised clinical trial to test the effect of a technology-based intervention to improve virological suppression among young adults with HIV in the USA. BMJ Open. 2023 10 06; 13(10):e077676. Saberi P, Stoner MCD, McCuistian CL, Balaban C, Ming K, Wagner D, Chakraborty B, Smith L, Sukhija-Cohen A, Neilands TB, Gruber VA, Johnson MO. PMID: 37802624; PMCID: PMC10565330.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    4. Pre-implementation Assessment of Tobacco Cessation Interventions in Substance Use Disorder Residential Programs in California. Subst Use Misuse. 2022; 57(9):1345-1355. Fokuo JK, McCuistian CL, Masson CL, Gruber VA, Straus E, Wong J, Guydish JR. PMID: 35621319; PMCID: PMC10083040.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    5. Methadone maintenance patients lack analgesic response to a cumulative intravenous dose of 32 mg of hydromorphone. Drug Alcohol Depend. 2021 09 01; 226:108869. Agin-Liebes G, Huhn AS, Strain EC, Bigelow GE, Smith MT, Edwards RR, Gruber VA, Tompkins DA. PMID: 34216862; PMCID: PMC9559787.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    6. COVID-19 vaccine trust among clients in a sample of California residential substance use treatment programs. Drug Alcohol Depend. 2021 08 01; 225:108812. Masson CL, McCuistian C, Straus E, Elahi S, Chen M, Gruber VA, Le T, Guydish J. PMID: 34174773; PMCID: PMC8221747.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    7. Addressing HIV care, mental health and substance use among youth and young adults in the Bay Area: description of an intervention to improve information, motivation and behavioural skills. BMJ Open. 2021 Apr 08; 11(4):e042713. McCuistian C, Wootton AR, Legnitto-Packard D, Gruber VA, Dawson-Rose C, Johnson MO, Saberi P. PMID: 38058024; PMCID: PMC8039246.
      View in: PubMed   Mentions: 1     Fields:    
    8. Video-Counseling Intervention to Address HIV Care Engagement, Mental Health, and Substance Use Challenges: A Pilot Randomized Clinical Trial for Youth and Young Adults Living with HIV. Telemed Rep. 2021; 2(1):14-25. Saberi P, McCuistian C, Agnew E, Wootton AR, Legnitto Packard DA, Dawson-Rose C, Johnson MO, Gruber VA, Neilands TB. PMID: 33575683; PMCID: PMC7869821.
      View in: PubMed   Mentions: 10  
    9. Overcoming Technological Challenges: Lessons Learned from a Telehealth Counseling Study. Telemed J E Health. 2020 10; 26(10):1278-1283. Wootton AR, McCuistian C, Legnitto Packard DA, Gruber VA, Saberi P. PMID: 31800368.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    10. Telehealth and texting intervention to improve HIV care engagement, mental health and substance use outcomes in youth living with HIV: a pilot feasibility and acceptability study protocol. BMJ Open. 2019 07 16; 9(7):e028522. Wootton AR, Legnitto DA, Gruber VA, Dawson-Rose C, Neilands TB, Johnson MO, Saberi P. PMID: 31315868; PMCID: PMC6661640.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    11. Use of technology for delivery of mental health and substance use services to youth living with HIV: a mixed-methods perspective. AIDS Care. 2020 08; 32(8):931-939. Saberi P, Dawson Rose C, Wootton AR, Ming K, Legnitto D, Jeske M, Pollack LM, Johnson MO, Gruber VA, Neilands TB. PMID: 31132864; PMCID: PMC6881543.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    12. Fair hearing outcomes of patients recommended discharge from methadone maintenance. J Subst Abuse Treat. 2017 12; 83:68-72. Chang JS, Chiu JD, Gruber VA, Sorensen JL. PMID: 28919058.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    13. Do cigarette graphic warnings encourage smokers to attend a smoking cessation programme: a quasi-experimental study. Tob Control. 2018 01; 27(1):43-49. Guydish J, Tajima B, Le T, Henderson C, Yip D, Gruber V, Garcia W, Delucchi KL. PMID: 27913790.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    14. A Pilot Study of a Readiness Group to Increase Initiation of Smoking Cessation Services among Women in Residential Addiction Treatment. J Subst Abuse Treat. 2016 Apr; 63:39-45. Guydish J, Gruber VA, Le T, Tajima B, Andrews KB, Leo H, Zura SK, Miller R, Tsoh JY. PMID: 26825975; PMCID: PMC4775306.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    15. Scientist–Practitioner Training at the Internship and Postdoctoral Level: Reflections Over Three Decades. Training and Education in Professional Psychology. 2015 May 1; 9(2):105-112. Muñoz MR, Sorensen SJ, Areán AP, Lieberman LA, Fields FL, Gruber GV, Hall HS, Kramer KJ, Leykin LY, McBurnett MK, McQuaid MJ, Pfiffner PL, Prochaska PJ, Scheidt SS, Shumway SM, Tsoh TJ, Van Horn VP, Sosa SH, McNiel MD. .
      View in: Publisher Site   Mentions:
    16. Uptake of HIV testing in substance use disorder treatment programs that offer on-site testing. AIDS Behav. 2015 Mar; 19(3):536-42. Kyle TL, Horigian VE, Tross S, Gruber VA, Pereyra M, Mandler RN, Feaster DJ, Metsch LR. PMID: 25074737; PMCID: PMC4312252.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansPHPublic Health
    17. Community-based harm reduction substance abuse treatment with methamphetamine-using men who have sex with men. J Urban Health. 2014 Jun; 91(3):555-67. Carrico AW, Flentje A, Gruber VA, Woods WJ, Discepola MV, Dilworth SE, Neilands TB, Jain J, Siever MD. PMID: 24744105; PMCID: PMC4074324.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    18. Interaction of disulfiram with antiretroviral medications: efavirenz increases while atazanavir decreases disulfiram effect on enzymes of alcohol metabolism. Am J Addict. 2014 Mar-Apr; 23(2):137-44. McCance-Katz EF, Gruber VA, Beatty G, Lum P, Ma Q, DiFrancesco R, Hochreiter J, Wallace PK, Faiman MD, Morse GD. PMID: 24118434; PMCID: PMC3984379.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    19. Interactions between alcohol and the HIV entry inhibitor Maraviroc. J Int Assoc Provid AIDS Care. 2013 Nov-Dec; 12(6):375-7. Gruber VA, Rainey PM, Lum PJ, Beatty GW, Aweeka FT, McCance-Katz EF. PMID: 23881910; PMCID: PMC4100473.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    20. Interactions between alcohol and the antiretroviral medications ritonavir or efavirenz. J Addict Med. 2013 Jul-Aug; 7(4):264-70. McCance-Katz EF, Gruber VA, Beatty G, Lum PJ, Rainey PM. PMID: 23666322; PMCID: PMC3737351.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    21. Directly administered antiretroviral therapy: pilot study of a structural intervention in methadone maintenance. J Subst Abuse Treat. 2012 Dec; 43(4):418-23. Sorensen JL, Haug NA, Larios S, Gruber VA, Tulsky J, Powelson E, Logan DP, Shapiro B. PMID: 23007110; PMCID: PMC3484182.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    22. Untreated HIV infection is associated with higher blood alcohol levels. J Acquir Immune Defic Syndr. 2012 Jul 01; 60(3):282-8. McCance-Katz EF, Lum PJ, Beatty G, Gruber VA, Peters M, Rainey PM. PMID: 22495786; PMCID: PMC3723399.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    23. Interactions between buprenorphine and the protease inhibitors darunavir-ritonavir and fosamprenavir-ritonavir. Clin Infect Dis. 2012 Feb 01; 54(3):414-23. Gruber VA, Rainey PM, Moody DE, Morse GD, Ma Q, Prathikanti S, Pade PA, Alvanzo AA, McCance-Katz EF. PMID: 22100576; PMCID: PMC3258270.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    24. Methadone, buprenorphine, and street drug interactions with antiretroviral medications. Curr HIV/AIDS Rep. 2010 Aug; 7(3):152-60. Gruber VA, McCance-Katz EF. PMID: 20532839; PMCID: PMC2892618.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    25. Multi-center trial of baclofen for abstinence initiation in severe cocaine-dependent individuals. Drug Alcohol Depend. 2009 Jul 01; 103(1-2):59-64. Kahn R, Biswas K, Childress AR, Shoptaw S, Fudala PJ, Gorgon L, Montoya I, Collins J, McSherry F, Li SH, Chiang N, Alathari H, Watson D, Liberto J, Beresford T, Stock C, Wallace C, Gruber V, Elkashef A. PMID: 19414226; PMCID: PMC2774896.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    26. A randomized trial of 6-month methadone maintenance with standard or minimal counseling versus 21-day methadone detoxification. Drug Alcohol Depend. 2008 Apr 01; 94(1-3):199-206. Gruber VA, Delucchi KL, Kielstein A, Batki SL. PMID: 18243585; PMCID: PMC2821580.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    27. Adoption of evidence-based practices among substance abuse treatment providers. J Drug Educ. 2008; 38(2):181-92. Haug NA, Shopshire M, Tajima B, Gruber V, Guydish J. PMID: 18724657; PMCID: PMC2742313.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    28. Psychosocial Predictors of Adherence to Highly Active Antiretroviral Therapy. Journal of HIV/AIDS & Social Services. 2007 Mar 27; 6(1-2):23-37. Gruber GV, Sorensen SJ, Haug HN. .
      View in: Publisher Site   Mentions:
    29. HAART adherence strategies for methadone clients who are HIV-positive: a treatment manual for implementing contingency management and medication coaching. Behav Modif. 2006 Nov; 30(6):752-81. Haug NA, Sorensen JL, Gruber VA, Lollo N, Roth G. PMID: 17050764.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    30. Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial. Drug Alcohol Depend. 2007 Apr 17; 88(1):54-63. Sorensen JL, Haug NA, Delucchi KL, Gruber V, Kletter E, Batki SL, Tulsky JP, Barnett P, Hall S. PMID: 17056206; PMCID: PMC1976289.
      View in: PubMed   Mentions: 102     Fields:    Translation:Humans
    31. Gender differences among HIV-positive methadone maintenance patients enrolled in a medication adherence trial. AIDS Care. 2005 Nov; 17(8):1022-9. Haug NA, Sorensen JL, Lollo ND, Gruber VA, Delucchi KL, Hall SM. PMID: 16176898.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    32. A controlled trial of methadone treatment combined with directly observed isoniazid for tuberculosis prevention in injection drug users. Drug Alcohol Depend. 2002 May 01; 66(3):283-93. Batki SL, Gruber VA, Bradley JM, Bradley M, Delucchi K. PMID: 12062463.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCTClinical Trials
    33. Longer episodes of community residential care reduce substance abuse patients' readmission rates. J Stud Alcohol. 1995 Jul; 56(4):433-43. Moos RH, Pettit B, Gruber V. PMID: 7674679.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    34. Characteristics and outcomes of three models of community residential care for abuse patients. J Subst Abuse. 1995; 7(1):99-116. Moos RH, Pettit B, Gruber VA. PMID: 7655315.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    35. Pregnancy and contraception use among urban Rwandan women after HIV testing and counseling. Am J Public Health. 1993 May; 83(5):705-10. Allen S, Serufilira A, Gruber V, Kegeles S, Van de Perre P, Carael M, Coates TJ. PMID: 8484453; PMCID: PMC1694707.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    Valerie's Networks
    Concepts (168)
    Derived automatically from this person's publications.
    _
    Co-Authors (26)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _